DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,048 filers reported holding DANAHER CORPORATION in Q3 2016. The put-call ratio across all filers is 0.17 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $8,344,000 | -1.7% | 32,304 | -3.5% | 9.87% | +15.0% |
Q2 2022 | $8,488,000 | -15.0% | 33,480 | -1.6% | 8.58% | +0.5% |
Q1 2022 | $9,981,000 | -10.8% | 34,026 | 0.0% | 8.54% | -2.1% |
Q4 2021 | $11,195,000 | +8.1% | 34,026 | 0.0% | 8.72% | +10.5% |
Q3 2021 | $10,359,000 | +13.4% | 34,026 | 0.0% | 7.89% | +1.2% |
Q2 2021 | $9,131,000 | +14.0% | 34,026 | -4.4% | 7.80% | +6.8% |
Q1 2021 | $8,008,000 | -33.1% | 35,578 | -34.0% | 7.30% | -37.5% |
Q4 2020 | $11,975,000 | +3.2% | 53,908 | 0.0% | 11.69% | -5.9% |
Q3 2020 | $11,608,000 | +21.8% | 53,908 | 0.0% | 12.43% | +11.4% |
Q2 2020 | $9,533,000 | +27.8% | 53,908 | 0.0% | 11.15% | +0.3% |
Q1 2020 | $7,461,000 | -9.8% | 53,908 | 0.0% | 11.12% | +25.5% |
Q4 2019 | $8,274,000 | +5.9% | 53,908 | -0.3% | 8.86% | -2.7% |
Q3 2019 | $7,813,000 | +1.1% | 54,096 | 0.0% | 9.10% | -3.3% |
Q2 2019 | $7,731,000 | +0.5% | 54,096 | -7.2% | 9.41% | -5.7% |
Q1 2019 | $7,692,000 | +30.3% | 58,266 | +1.8% | 9.98% | +15.4% |
Q4 2018 | $5,904,000 | +40.4% | 57,251 | +48.0% | 8.65% | +70.9% |
Q3 2018 | $4,204,000 | +156.0% | 38,692 | +98.9% | 5.06% | +171.6% |
Q2 2017 | $1,642,000 | -22.5% | 19,453 | -21.5% | 1.86% | -17.1% |
Q1 2017 | $2,119,000 | -38.5% | 24,774 | -44.1% | 2.25% | -27.3% |
Q4 2016 | $3,448,000 | -27.8% | 44,291 | -27.3% | 3.09% | -25.2% |
Q3 2016 | $4,775,000 | +16.9% | 60,915 | +50.7% | 4.13% | -6.6% |
Q2 2016 | $4,084,000 | – | 40,432 | – | 4.42% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
Third Point | 3,570,000 | $494,124,000 | 7.88% |